vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and Astrana Health, Inc. (ASTH). Click either name above to swap in a different company.
Astrana Health, Inc. is the larger business by last-quarter revenue ($950.5M vs $821.5M, roughly 1.2× Acadia Healthcare Company, Inc.). Astrana Health, Inc. runs the higher net margin — 0.7% vs -143.3%, a 144.0% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 6.1%). Astrana Health, Inc. produced more free cash flow last quarter ($-6.0M vs $-179.5M). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 3.4%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
ACHC vs ASTH — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $821.5M | $950.5M |
| Net Profit | $-1.2B | $6.6M |
| Gross Margin | — | — |
| Operating Margin | -142.4% | 1.9% |
| Net Margin | -143.3% | 0.7% |
| Revenue YoY | 6.1% | 42.9% |
| Net Profit YoY | -3710.4% | 184.4% |
| EPS (diluted) | $-12.98 | $0.12 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $821.5M | $950.5M | ||
| Q3 25 | $851.6M | $956.0M | ||
| Q2 25 | $869.2M | $654.8M | ||
| Q1 25 | $770.5M | $620.4M | ||
| Q4 24 | $774.2M | $665.2M | ||
| Q3 24 | $815.6M | $478.7M | ||
| Q2 24 | $796.0M | $486.3M | ||
| Q1 24 | $768.1M | $404.4M |
| Q4 25 | $-1.2B | $6.6M | ||
| Q3 25 | $36.2M | $373.0K | ||
| Q2 25 | $30.1M | $9.4M | ||
| Q1 25 | $8.4M | $6.7M | ||
| Q4 24 | $32.6M | $-7.8M | ||
| Q3 24 | $68.1M | $16.1M | ||
| Q2 24 | $78.5M | $19.2M | ||
| Q1 24 | $76.4M | $14.8M |
| Q4 25 | -142.4% | 1.9% | ||
| Q3 25 | 4.7% | 2.0% | ||
| Q2 25 | 5.8% | 3.1% | ||
| Q1 25 | 1.7% | 3.3% | ||
| Q4 24 | 4.9% | 0.1% | ||
| Q3 24 | 12.1% | 5.9% | ||
| Q2 24 | 13.4% | 6.2% | ||
| Q1 24 | 12.9% | 7.5% |
| Q4 25 | -143.3% | 0.7% | ||
| Q3 25 | 4.3% | 0.0% | ||
| Q2 25 | 3.5% | 1.4% | ||
| Q1 25 | 1.1% | 1.1% | ||
| Q4 24 | 4.2% | -1.2% | ||
| Q3 24 | 8.4% | 3.4% | ||
| Q2 24 | 9.9% | 3.9% | ||
| Q1 24 | 9.9% | 3.7% |
| Q4 25 | $-12.98 | $0.12 | ||
| Q3 25 | $0.40 | $0.01 | ||
| Q2 25 | $0.33 | $0.19 | ||
| Q1 25 | $0.09 | $0.14 | ||
| Q4 24 | $0.36 | $-0.14 | ||
| Q3 24 | $0.74 | $0.33 | ||
| Q2 24 | $0.85 | $0.40 | ||
| Q1 24 | $0.83 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $133.2M | $429.5M |
| Total DebtLower is stronger | $2.5B | — |
| Stockholders' EquityBook value | $1.9B | $779.3M |
| Total Assets | $5.5B | $2.2B |
| Debt / EquityLower = less leverage | 1.28× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $133.2M | $429.5M | ||
| Q3 25 | $118.7M | $463.4M | ||
| Q2 25 | $131.4M | $342.1M | ||
| Q1 25 | $91.2M | $260.9M | ||
| Q4 24 | $76.3M | $290.8M | ||
| Q3 24 | $82.1M | $350.3M | ||
| Q2 24 | $77.2M | $327.7M | ||
| Q1 24 | $77.3M | $337.3M |
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — | ||
| Q1 24 | $1.9B | — |
| Q4 25 | $1.9B | $779.3M | ||
| Q3 25 | $3.1B | $775.5M | ||
| Q2 25 | $3.1B | $765.5M | ||
| Q1 25 | $3.0B | $745.4M | ||
| Q4 24 | $3.1B | $712.7M | ||
| Q3 24 | $3.0B | $704.6M | ||
| Q2 24 | $3.0B | $678.9M | ||
| Q1 24 | $2.9B | $653.5M |
| Q4 25 | $5.5B | $2.2B | ||
| Q3 25 | $6.4B | $2.2B | ||
| Q2 25 | $6.3B | $1.4B | ||
| Q1 25 | $6.1B | $1.3B | ||
| Q4 24 | $6.0B | $1.4B | ||
| Q3 24 | $5.9B | $1.3B | ||
| Q2 24 | $5.7B | $1.3B | ||
| Q1 24 | $5.5B | $1.2B |
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — | ||
| Q1 24 | 0.65× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-86.3M | $-2.9M |
| Free Cash FlowOCF − Capex | $-179.5M | $-6.0M |
| FCF MarginFCF / Revenue | -21.8% | -0.6% |
| Capex IntensityCapex / Revenue | 11.3% | 0.3% |
| Cash ConversionOCF / Net Profit | — | -0.44× |
| TTM Free Cash FlowTrailing 4 quarters | $-439.9M | $104.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-86.3M | $-2.9M | ||
| Q3 25 | $73.2M | $10.0M | ||
| Q2 25 | $133.5M | $90.9M | ||
| Q1 25 | $11.5M | $16.6M | ||
| Q4 24 | $116.7M | $-10.9M | ||
| Q3 24 | $163.1M | $34.0M | ||
| Q2 24 | $171.1M | $23.2M | ||
| Q1 24 | $-321.3M | $6.0M |
| Q4 25 | $-179.5M | $-6.0M | ||
| Q3 25 | $-63.0M | $7.4M | ||
| Q2 25 | $-34.2M | $89.5M | ||
| Q1 25 | $-163.2M | $13.6M | ||
| Q4 24 | $-86.8M | $-13.5M | ||
| Q3 24 | $-27.1M | $31.7M | ||
| Q2 24 | $16.9M | $20.4M | ||
| Q1 24 | $-463.7M | $5.6M |
| Q4 25 | -21.8% | -0.6% | ||
| Q3 25 | -7.4% | 0.8% | ||
| Q2 25 | -3.9% | 13.7% | ||
| Q1 25 | -21.2% | 2.2% | ||
| Q4 24 | -11.2% | -2.0% | ||
| Q3 24 | -3.3% | 6.6% | ||
| Q2 24 | 2.1% | 4.2% | ||
| Q1 24 | -60.4% | 1.4% |
| Q4 25 | 11.3% | 0.3% | ||
| Q3 25 | 16.0% | 0.3% | ||
| Q2 25 | 19.3% | 0.2% | ||
| Q1 25 | 22.7% | 0.5% | ||
| Q4 24 | 26.3% | 0.4% | ||
| Q3 24 | 23.3% | 0.5% | ||
| Q2 24 | 19.4% | 0.6% | ||
| Q1 24 | 18.5% | 0.1% |
| Q4 25 | — | -0.44× | ||
| Q3 25 | 2.02× | 26.69× | ||
| Q2 25 | 4.43× | 9.65× | ||
| Q1 25 | 1.37× | 2.48× | ||
| Q4 24 | 3.58× | — | ||
| Q3 24 | 2.39× | 2.11× | ||
| Q2 24 | 2.18× | 1.21× | ||
| Q1 24 | -4.21× | 0.40× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $451.2M | 55% |
| Comprehensive Treatment Centers | $144.2M | 18% |
| Medicare | $113.7M | 14% |
| Residential Treatment Centers | $89.7M | 11% |
| Self Payor | $16.1M | 2% |
| Other Payor | $10.7M | 1% |
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
